Literature DB >> 31258821

Development and validation of nomogram estimating post-surgery hospital stay of lung cancer patients: relevance for predictive, preventive, and personalized healthcare strategies.

Xiang-Lin Hu1, Song-Tao Xu2, Xiao-Cen Wang1, Jin-Long Luo1, Dong-Ni Hou1, Xiao-Min Zhang3, Chen Bao1, Dong Yang1, Yuan-Lin Song1, Chun-Xue Bai1.   

Abstract

OBJECTIVE: In the era of fast track surgery, early and accurately estimating whether postoperative length of stay (p-LOS) will be prolonged after lung cancer surgery is very important, both for patient's discharge planning and hospital bed management. Pulmonary function tests (PFTs) are very valuable routine examinations which should not be underutilized before lung cancer surgery. Thus, this study aimed to establish an accurate but simple prediction tool, based on PFTs, for achieving a personalized prediction of prolonged p-LOS in patients following lung resection.
METHODS: The medical information of 1257 patients undergoing lung cancer surgery were retrospectively reviewed and served as the training set. p-LOS exceeding the third quartile value was considered prolonged. Using logistic regression analyses, potential predictors of prolonged p-LOS were identified among various preoperative factors containing PFTs and intraoperative factors. A nomogram was constructed and subjected to internal and external validation.
RESULTS: Five independent risk factors for prolonged p-LOS were identified, including older age, being male, and ratio of residual volume to total lung capacity (RV/TLC) ≥ 45.0% which is the only modifiable risk factor, more invasive surgical approach, and surgical type. The nomogram comprised of these five predictors exhibited sufficient predictive accuracy, with the area under the receiver operating characteristic curve (AUC) of 0.76 [95% confidence interval (CI) 0.73-0.79] in the internal validation. Also its predictive performance remained fine in the external validation, with the AUC of 0.70 (95% CI 0.60-0.79). The calibration curves showed satisfactory agreements between the model predicted probability and the actually observed probability.
CONCLUSIONS: Preoperative amelioration of RV/TLC may prevent lung cancer patients from unnecessary prolonged p-LOS. The integrated nomogram we developed could provide personalized risk prediction of prolonged p-LOS. This prediction tool may help patients perceive expected hospital stays and enable clinicians to achieve better bed management after lung cancer surgery.

Entities:  

Keywords:  Advanced healthcare; Economic burden; Hospitalization; Individualized patient profile; Length of stay; Lung cancer; Nomogram; Prediction model; Predictive preventive personalized medicine; Pulmonary function tests; Risk assessment; Surgery

Year:  2019        PMID: 31258821      PMCID: PMC6562016          DOI: 10.1007/s13167-019-00168-z

Source DB:  PubMed          Journal:  EPMA J        ISSN: 1878-5077            Impact factor:   6.543


  38 in total

1.  Inspiratory capacity as a preoperative assessment of patients undergoing thoracic surgery.

Authors:  Masaki Matsuo; Naozumi Hashimoto; Noriyasu Usami; Kazuyoshi Imaizumi; Kenji Wakai; Tsutomu Kawabe; Kohei Yokoi; Yoshinori Hasegawa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-03

2.  The quality metric prolonged length of stay misses clinically important adverse events.

Authors:  Farhood Farjah; Feiran Lou; Valerie W Rusch; Nabil P Rizk
Journal:  Ann Thorac Surg       Date:  2012-06-27       Impact factor: 4.330

Review 3.  How to build and interpret a nomogram for cancer prognosis.

Authors:  Alexia Iasonos; Deborah Schrag; Ganesh V Raj; Katherine S Panageas
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

Review 4.  Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes.

Authors:  Stacy Raviv; Keenan A Hawkins; Malcolm M DeCamp; Ravi Kalhan
Journal:  Am J Respir Crit Care Med       Date:  2010-12-22       Impact factor: 21.405

5.  Impact of hospital volume on chest tube duration, length of stay, and mortality after lobectomy.

Authors:  Hiroshi Otake; Hideo Yasunaga; Hiromasa Horiguchi; Noriyuki Matsutani; Shinya Matsuda; Kazuhiko Ohe
Journal:  Ann Thorac Surg       Date:  2011-09       Impact factor: 4.330

6.  Can nomograms be superior to other prediction tools?

Authors:  Shahrokh F Shariat; Umberto Capitanio; Claudio Jeldres; Pierre I Karakiewicz
Journal:  BJU Int       Date:  2008-09-18       Impact factor: 5.588

7.  Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Alessandro Brunelli; Anthony W Kim; Kenneth I Berger; Doreen J Addrizzo-Harris
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

8.  Preoperative pulmonary rehabilitation in patients with lung cancer and chronic obstructive pulmonary disease.

Authors:  Duilio Divisi; Cinzia Di Francesco; Gabriella Di Leonardo; Roberto Crisci
Journal:  Eur J Cardiothorac Surg       Date:  2012-05-15       Impact factor: 4.191

9.  General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine.

Authors:  Olga Golubnitschaja; Vincenzo Costigliola
Journal:  EPMA J       Date:  2012-11-01       Impact factor: 6.543

10.  Time for new guidelines in advanced healthcare: the mission of The EPMA Journal to promote an integrative view in predictive, preventive and personalized medicine.

Authors:  Olga Golubnitschaja
Journal:  EPMA J       Date:  2012-03-28       Impact factor: 6.543

View more
  1 in total

1.  Shortness of Breath on Day 1 After Surgery Alerting the Presence of Early Respiratory Complications After Surgery in Lung Cancer Patients.

Authors:  Qingsong Yu; Hongfan Yu; Wei Xu; Yang Pu; Yuxian Nie; Wei Dai; Xing Wei; Xin Shelley Wang; Charles S Cleeland; Qiang Li; Qiuling Shi
Journal:  Patient Prefer Adherence       Date:  2022-03-19       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.